Ratnakar Securities Pvt. Ltd.

JENBURKT PHARMACEUTICALS LTD.

NSE : NABSE : 524731ISIN CODE : INE354A01013Industry : Pharmaceuticals & DrugsHouse : Private

BSE783.00-8.8 (-1.11 %)

PREV CLOSE ( ) 791.80

OPEN PRICE ( ) 791.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3588

TODAY'S LOW / HIGH ( )752.70 810.00

52 WK LOW / HIGH ( ) 586.9925

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1985

Management Info

Ashish U Bhuta - Chairman Ashish U Bhuta - Managing Director

Registered Office

Address Nirmala Apartments,93 Jayprakash Road,Andheri (West),
Mumbai,
Maharashtra-400058

Phone 022-67603603

Email investor@jenburkt.com / info@jenburkt.com

Website www.jenburkt.com

Registrars Details

Bigshare Services Pvt Ltd

Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai

Listing : BSE

NEWS

02Mar Jenburkt Pharmaceuticals informs about
In terms of Regulation 39(3) of the Securities and Exchange Board of Ind..

13Dec Jenburkt Pharmaceuticals informs about
Jenburkt Pharmaceuticals has informed that the information received from..

09Aug Jenburkt Pharmaceuticals informs about
Pursuant to Regulation 39(3) of the Securities and Exchange Board of Ind..

14Jul Jenburkt Pharmaceuticals informs about
Pursuant to Regulation 39(3) of the Securities and Exchange Board of Ind..

07Jul Jenburkt Pharmaceuticals informs about
Pursuant to Regulation 39(3) of the Securities and Exchange Board of Ind..

Financials

in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	54.03	246.06
Gross Profit	78.39	328.64
Operating Profit	85.39	354.9
Net Sales	356.6	1367.49

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE) 26643.70 (0.58%)	M.Cap ( in Cr)56616.00
Pfizer (BSE) 4473.85 (1.59%)	M.Cap ( in Cr)20466.85
Glaxosmithkline Phar (BSE) 2355.75 (2.80%)	M.Cap ( in Cr)39907.83
Concord Biotech (BSE) 1494.85 (4.43%)	M.Cap ( in Cr)15638.55
Zydus Lifesciences (BSE) 1104.45 (5.00%)	M.Cap ( in Cr)111133.51

Shareholding Pattern

	NON-INSTITUTION	52.77%
	PROMOTERS	47.23%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

attention investors
kyc
ipo
ibt trading

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

JENBURKT PHARMACEUTICALS LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES